250. Interspinous process distraction compared to nonoperative care for moderate lumbar degenerative disc disease: results of the FDA IDE clinical trial.

MLA

Gornet, Matthew F., et al. “250. Interspinous Process Distraction Compared to Nonoperative Care for Moderate Lumbar Degenerative Disc Disease: Results of the FDA IDE Clinical Trial.” Spine Journal, vol. 19, Sept. 2019, pp. S122–23. EBSCOhost, https://doi.org/10.1016/j.spinee.2019.05.265.

APA

Gornet, M. F., Bailey, A. S., Eltahawy, H. A., Sasso, R. C., Cheng, W. K., Palmer, S., Dohring, E. J., Taha, J., Schranck, F. W., & Copay, A. G. (2019). 250. Interspinous process distraction compared to nonoperative care for moderate lumbar degenerative disc disease: results of the FDA IDE clinical trial. Spine Journal, 19, S122–S123. https://doi.org/10.1016/j.spinee.2019.05.265

Chicago

Gornet, Matthew F., Alexander S. Bailey, Hazem A. Eltahawy, Rick C. Sasso, Wayne K. Cheng, Sylvain Palmer, Edward J. Dohring, Jamal Taha, Francine W. Schranck, and Anne G. Copay. 2019. “250. Interspinous Process Distraction Compared to Nonoperative Care for Moderate Lumbar Degenerative Disc Disease: Results of the FDA IDE Clinical Trial.” Spine Journal 19 (September): S122–23. doi:10.1016/j.spinee.2019.05.265.